Marketing agreement between Artel and STRATEC

STRATEC Biomedical AG / Key word(s): Agreement/Alliance

2015-01-12 / 09:29

Marketing agreement between Artel and STRATEC

Birkenfeld, January 12, 2015

STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, TecDAX) and Artel, Westbrook, Maine, USA, the worldwide leader in laboratory liquid handling quality assurance, have announced an exclusive marketing agreement for STRATEC's patented "Tholos" liquid handling quality assurance instrumentation solution.

Under the agreement, effective as of January 1, 2015, Artel will exclusively market the "Tholos" technology developed by STRATEC under Artel's brand name in its core markets.

STRATEC's "Tholos" measures the volume of liquids in reaction wells using an innovative pressure-based technology that accurately and repeatedly assesses volume regardless of the size of the reaction well, its shape or coloring. This makes it possible to record critical process parameters for sample handling operations in laboratory applications in the pharmaceutical industry, life science research, production and assay development. The system can therefore be used as an in-process control for nearly all types of liquid handling applications.

"Our customers will benefit from this powerful technology, which further enhances their ability to ensure high-quality results", says Kirby Pilcher, president of Artel. "The strategic partnership with STRATEC, a leader in providing automated systems used in laboratories worldwide, has resulted in a perfect addition to Artel's portfolio of liquid handling quality assurance products and services".

"The system is an innovative volume control solution that closes a gap in in-process control for high throughput automation processes", added Marcus Wolfinger, Chairman, Board of Management of STRATEC. "We are very proud to have gained Artel, the global market leader in liquid handling quality assurance, as a partner".

About Artel
Laboratories worldwide depend upon Artel technology and expertise to standardize and optimize their liquid handling instruments and processes, and to give them total confidence in their results. Since 1982, Artel has been solving liquid handling quality, productivity and compliance challenges in laboratories in pharmaceutical and biotechnology research, regulatory bodies, academia, clinical diagnostics, forensics, public health, agbio, food quality and safety and environmental testing.

Artel provides quality assurance systems and a broad and fully customizable range of support, training and consultation services for laboratories using automated liquid handling instrumentation and manual pipettes. For more information visit

STRATEC Biomedical AG ( designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies.

Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the TecDAX select index of the German Stock Exchange.

Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Corporate Communications
Gewerbestr. 37, 75217 Birkenfeld
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999

2015-01-12 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at and

311907  2015-01-12